BriaCell Therapeutics (BCTX) Stock Price & Financial Analysis
BriaCell Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About BriaCell Therapeutics
What is the current stock price for BCTX?
As of the latest trading session, BCTX stock trades at $3.35. The 52-week range is $3.60–$37.20, with a day range of $3.11–$3.40.
What is the P/E ratio for BCTX?
The P/E ratio (Price-to-Earnings) for BCTX is shown in the Key Statistics section. This valuation metric helps compare BriaCell Therapeutics Corp. to industry peers.
Does BCTX pay dividends?
BriaCell Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BCTX?
Analyst ratings and recommendations for BCTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BCTX?
BriaCell Therapeutics's market capitalization is $9.4M, classifying it as a micro-cap company. BriaCell Therapeutics operates in the Healthcare sector within the Biotechnology industry.